Nuvation Bio Inc. Other Nonoperating Expense
Nuvation Bio Inc. (NUVB) reported Other Nonoperating Expense of $109.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-06.
Financial Statements › Income Statement › Other Income
us-gaap:OtherNonoperatingExpense · last filed 2025-03-06
- Nuvation Bio Inc. other nonoperating expense for fiscal 2024 was $109.00K.
- Nuvation Bio Inc. other nonoperating expense for fiscal 2023 was $0.00.
| Period end | Other Nonoperating Expense 12 month |
|---|---|
| 2024-12-31 | $109.00K 10-K · filed 2025-03-06 |
| 2023-12-31 | $0.00 10-K · filed 2025-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B |